Cargando…

Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses

Depression is a common comorbid condition in Parkinson’s disease (PD). Patients with depression have a two-fold increased risk to develop PD. Further, depression symptoms often precede motor symptoms in PD and are frequent at all stages of the disease. However, the influence of a depressive state on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schintu, Nicoletta, Zhang, Xiaoqun, Stroth, Nikolas, Mathé, Aleksander A., Andrén, Per E., Svenningsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099513/ https://www.ncbi.nlm.nih.gov/pubmed/32265703 http://dx.doi.org/10.3389/fphar.2020.00304

Ejemplares similares

Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism
por: Monnot, Cyril, et al.
Publicado: (2017)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
por: Svenningsson, Per, et al.
Publicado: (2017)

Antidepressant-like properties of sarizotan in experimental Parkinsonism
por: Zhang, Xiaoqun, et al.
Publicado: (2011)

Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition
por: Vallianatou, Theodosia, et al.
Publicado: (2019)

Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA–induced dyskinesia
por: Fridjonsdottir, Elva, et al.
Publicado: (2021)

Cell‐ and region‐specific expression of depression‐related protein p11 (S100a10) in the brain
por: Milosevic, Ana, et al.
Publicado: (2016)

Deficits in Motor Performance, Neurotransmitters and Synaptic Plasticity in Elderly and Experimental Parkinsonian Mice Lacking GPR37
por: Zhang, Xiaoqun, et al.
Publicado: (2020)

Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine
por: Zhang, Xiaoqun, et al.
Publicado: (2018)

Altered explorative strategies and reactive coping style in the FSL rat model of depression
por: Magara, Salvatore, et al.
Publicado: (2015)

Cross-validated Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging Quantitation Protocol for a Pharmaceutical Drug and Its Drug-Target Effects in the Brain Using Time-of-Flight and Fourier Transform Ion Cyclotron Resonance Analyzers
por: Källback, Patrik, et al.
Publicado: (2020)

Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents
por: He, Yachao, et al.
Publicado: (2023)

Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease
por: Paslawski, Wojciech, et al.
Publicado: (2023)

l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson’s Disease
por: Goshima, Yoshio, et al.
Publicado: (2019)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
por: Svenningsson, Per, et al.
Publicado: (2015)

Advances in non-dopaminergic treatments for Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
por: Miguelez, Cristina, et al.
Publicado: (2020)

Parkinson’s disease, dopaminergic drugs and the plant world
por: Kempster, Peter, et al.
Publicado: (2022)

Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model
por: Kaya, Ibrahim, et al.
Publicado: (2023)

α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients
por: Paslawski, Wojciech, et al.
Publicado: (2019)

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
por: Huh, Eugene, et al.
Publicado: (2019)

Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson’s Disease
por: dos Santos Pereira, Maurício, et al.
Publicado: (2021)

FSL‐MRS: An end‐to‐end spectroscopy analysis package
por: Clarke, William T., et al.
Publicado: (2020)

Antioxidants Attenuate Isolation- and L-DOPA-Induced Aggression in Mice
por: Hira, Sundas, et al.
Publicado: (2018)

Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa–Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson’s Rats
por: Wang, Wen-Wen, et al.
Publicado: (2019)

Prenatal Exposure to Gabapentin Alters the Development of Ventral Midbrain Dopaminergic Neurons
por: Alsanie, Walaa F., et al.
Publicado: (2022)

Basal ganglia neuropeptides show abnormal processing associated with L-DOPA-induced dyskinesia
por: Hulme, Heather, et al.
Publicado: (2022)

5-HT6 receptor agonism facilitates emotional learning
por: Pereira, Marcela, et al.
Publicado: (2015)

Altered cerebellar connectivity in Parkinson's patients ON and OFF L-DOPA medication
por: Festini, Sara B., et al.
Publicado: (2015)

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism
por: Baufreton, Jérôme, et al.
Publicado: (2018)

PS133. The role of Toxoplasma gondii in depression and anxiety - gene-environment interactions in the FSL rat model
por: Bay-Richter, Cecilie, et al.
Publicado: (2016)

Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency.
por: Jeon, B. S.
Publicado: (1997)

Quantitative Comparison of SPM, FSL, and Brainsuite for Brain MR Image Segmentation
por: Kazemi, K, et al.
Publicado: (2014)

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: A proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGE
por: Kultima, Kim, et al.
Publicado: (2006)

Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson’s disease and L-Dopa induced dyskinesia
por: Malave, Lauren, et al.
Publicado: (2021)

On-Tissue Chemical Derivatization for Comprehensive Mapping of Brain Carboxyl and Aldehyde Metabolites by MALDI–MS Imaging
por: Kaya, Ibrahim, et al.
Publicado: (2023)

Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia
por: Navailles, Sylvia, et al.
Publicado: (2012)

Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson’s Disease
por: Chen, Leilei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hvt1sm3tiblk1i1934qq7sdhd9